SAMHSA Extends OTP Exemption for In-Person Physical Exam for Buprenorphine Treatment

SAMHSA Extends OTP Exemption for In-Person Physical Exam for Buprenorphine Treatment

0 205

The Substance Abuse and Mental Health Services Administration (SAMHSA) announced today it is extending its opioid treatment program (OTP) exemption for an in-person physical evaluation for buprenorphine treatment for a period of one year from the end of the COVID-19 Public Health Emergency (PHE). The extension goes into effect upon the expiration of the COVID-19 PHE.

Read the full announcement.